Development and validation of a prognostic nomogram to predict overall survival (OS) in platinum-resistant ovarian cancer (PROC):  An AURELIA substudy.

Authors

null

Chee Lee

ANZGOG, NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia

Chee Lee , Emma Gibbs , Felicia T Roncolato , Lucy Claire Davies , Christine Le Maignan , Werner Meier , Maria Angeles Arcusa Lanza , Per Rosenberg , Claudia Marchetti , Ignace Vergote , Petronella Witteveen , Aristotelis Bamias , Sebastian Serra , Jocelyne Provencal , Gaetan De Rauglaudre , Val Gebski , Michael Friedlander , Eric Pujade-Lauraine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT00976911

Citation

J Clin Oncol 33, 2015 (suppl; abstr 5547)

DOI

10.1200/jco.2015.33.15_suppl.5547

Abstract #

5547

Poster Bd #

105

Abstract Disclosures

Similar Posters

First Author: Aristotelis Bamias

First Author: Gordon Taylor Moffat

First Author: Felicia Roncolato